Controlled Release Drug Delivery Market: Future Demand and Top Key Players Analysis | 2029

 Focused on real-world business use, this report highlights what’s changing in the controlled release drug delivery market and what companies should prepare for next.


How Much Is The Controlled Release Drug Delivery Market Worth?
The controlled release drug delivery market size has grown rapidly in recent years. It will grow from $65.44 billion in 2024 to $72.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to pioneering drug delivery systems, early polymer-based formulations, introduction of microencapsulation techniques, emergence of transdermal delivery, regulatory approvals, and standardization.

The controlled release drug delivery market size is expected to see rapid growth in the next few years. It will grow to $117.24 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to shift towards personalized medicine, technological integration for patient convenience, expansion of biologics and biosimilars, market expansion in developing regions, advancements in polymer science. Major trends in the forecast period include biodegradable and biocompatible materials, nanotechnology advancements, personalized medicine and targeted therapies, advances in implantable devices, innovative encapsulation techniques.

Get your free sample today:
Controlled Release Drug Delivery Market Share Insights By 2025 Sample

What Are The Current Leading Growth Drivers For Controlled Release Drug Delivery Market?
The rising prevalence of chronic diseases is expected to propel the growth of the controlled release drug delivery market. Chronic diseases are also known as noncommunicable diseases. It refers to conditions such as heart disease, cancer, and diabetes diseases lasting more than a year and requiring continuing medical care, limiting everyday activities, or both. Controlled-release drug delivery is crucial for treating chronic diseases. For patients with chronic illnesses that require years of treatment or those who reside in areas with limited resources and access to healthcare, drug delivery formulations that allow prolonged medication release are essential. For instance, in September 2022, according to report shared by the World Health Organization (WHO), a Switzerland-based health-specialized agency, every year, 41 million people die from chronic diseases, which accounts for 74 percent of all fatalities worldwide. Before the age of 70, 17 million individuals lose their lives to chronic illnesses. Moreover, 77 percent of deaths from chronic diseases occur in low- and middle-income nations. And these numbers are expected to rise in the future. Therefore, the rising prevalence of chronic diseases is driving the growth of the controlled release drug delivery market.

Which Segment Accounted For The Largest Controlled Release Drug Delivery Market Share?
The controlled release drug delivery market covered in this report is segmented –

1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

Controlled Release Drug Delivery Market Emerging Trends And Opportunities
Technological advancement is a key trend gaining popularity in the controlled-release drug delivery market. Major companies operating in the controlled-release drug delivery market are adopting new technologies to sustain their position in the market. For instance, in March 2022, Evonik Industries AG, a Germany-based pharmaceutical company, launched UDRATEC SoluFlow. UDRATEC SoluFlow is a novel microparticle technology designed to improve the solubility of active medicinal components in oral medication formulations. This emulsion-based process technique overcomes solubility barriers that traditional production methods cannot. EUDRATEC SoluFlow adds to Evonik Health Care's range of oral drug delivery system solutions, which includes oral excipients like EUDRAGIT functional polymers, ready-to-fill functional capsules like EUDRACAPTM, and other technologies and services to improve medication performance.

Which Are The Top Companies To Hold The Market Share In Controlled Release Drug Delivery Market?
Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

View the full controlled release drug delivery market report here:
https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Which Region Is Projected To Account For The Largest Share Of The Controlled Release Drug Delivery Market?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

#Contact Us:#

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


#Follow Us On:#

LinkedIn: The Business Research Company | LinkedIn

Comments

Popular posts from this blog

Cloud Services Market Evolution 2025-2034: Industry Growth Projections & Market Size Insights

Emerging Template Market Growth Trends: How Fertility Services is Reshaping Market Size & Industry Expansion

Digital Payments Market Evolution 2025-2034: Industry Growth Projections & Market Size Insights